Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ESPR will rise by +0.78% over the next 2 Weeks and hit $3.20 by Friday, July 24, 2026. In that time frame, ESPR's share price is expected to range between $3.19 and $3.22.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 24, 2026 | 3.20 | 3.21 | 3.23 |
| Jul 23, 2026 | 3.20 | 3.21 | 3.22 |
| Jul 22, 2026 | 3.20 | 3.21 | 3.22 |
| Jul 21, 2026 | 3.19 | 3.20 | 3.21 |
| Jul 20, 2026 | 3.19 | 3.20 | 3.21 |
| Jul 17, 2026 | 3.19 | 3.20 | 3.21 |
| Jul 16, 2026 | 3.18 | 3.19 | 3.20 |
| Jul 15, 2026 | 3.18 | 3.19 | 3.20 |
| Jul 14, 2026 | 3.18 | 3.19 | 3.19 |
| Jul 13, 2026 | 3.17 | 3.18 | 3.19 |
ESPR shares remained flat 0 in Friday, July 10, 2026's trading session, starting and closing at a previous close of $3.18 to move at $3.18. The stock demonstrated notable intraday movement (see ESPR's key stats for a full breakdown), fluctuating between $3.18 and $3.19, a +0.31% trading range. While recent weeks have seen some volatility, ESPR has managed to secure a +0.32% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 58.43M shares changing hands, 3.09M more than the previous session. This amounted to $185.81M in total market activity.
Will ESPR Continue Its Upward Trend?
According to analyst ratings and projections for ESPR, Esperion Therapeutics, Inc. shares are anticipated to increase by +1.48%, potentially reaching $3.23 per share by July 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for ESPR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the ESPR stock forecast, now is a good time to buy ESPR stock because its current trading price is -1.07% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ESPR covering social and institutional perspectives.
ESPR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ESPR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 62.61% to 64.75%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 54.16%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.48%, maintains a neutral outlook for the long term. Insights into ESPR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Esperion Therapeutics Short-Term Forecasts
ESPR Forecast For Next 5 Days
Our algorithm anticipates Esperion Therapeutics (ESPR) stock could hit $2.97 by Jul 20, 2026. This represents a -6.69% fall from today's price, following a -18.59% change over the past five days.
ESPR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Esperion Therapeutics, Inc. (ESPR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.04, which would mean a -4.40% decrease from the current price of $3.18. Projections for this period range from a high of $3.56 to a low of $2.44.
ESPR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Esperion Therapeutics's price over the next three months point to a rise. ESPR stock is expected to peak at $23.64 on Jul 28, 2026 before potentially dipping to $17.05 on Aug 27, 2026. On average, ESPR is likely to trade around $19.03 in the coming 90 days.
Esperion Therapeutics Stock Forecast 2025
Based on our predictive models, Esperion Therapeutics (ESPR) is expected to trade between $17.05 and $25.48 throughout 2026. This would result in an average price of $20.44, potentially offering investors a +542.77% return from current levels.
Esperion Therapeutics, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in July 2026. The price is predicted to move between $19.36 and $23.64, settling at an average of $21.82. This could translate to a +586.16% gain.
August 2026
Based on current market signals, Esperion Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $17.05 to $21.88, with a likely average price of $18.28. Investors could expect a potential return of +474.84%.
September 2026
Our predictive algorithms indicate Esperion Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $17.17–$18.65, with an average target of $17.92. This represents a positive outlook and a possible gain of +463.52%.
October 2026
Analyzing established trends, Esperion Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $18.53 and $19.75, averaging around $19.26. This suggests a +505.66% gain from current levels.
November 2026
Market indicators suggest Esperion Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $18.92 to $25.05, with a midpoint forecast of $20.86. The stock might deliver a +555.97% gain.
December 2026
Forecasting for December 2026, models estimate that Esperion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $23.39 and $25.48, averaging $24.73. This signals a positive trajectory with potential returns around +677.67%.
January 2027
According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in January 2027. The price is predicted to move between $14.32 and $23.15, settling at an average of $18.00. This could translate to a +466.04% gain.
February 2027
Based on current market signals, Esperion Therapeutics, Inc. is projected to trend february 2027. We forecast a trading range from $14.22 to $19.03, with a likely average price of $16.98. Investors could expect a potential return of +433.96%.
March 2027
Our predictive algorithms indicate Esperion Therapeutics, Inc. stock may see a shift in March 2027. The expected range spans $15.19–$17.82, with an average target of $16.54. This represents a positive outlook and a possible gain of +420.13%.
April 2027
Analyzing established trends, Esperion Therapeutics, Inc. looks set to move in April 2027. Projections place the stock between $12.80 and $17.76, averaging around $14.88. This suggests a +367.92% gain from current levels.
May 2027
Market indicators suggest Esperion Therapeutics, Inc. could experience notable changes during May 2027. Prices could fluctuate within $15.87 to $19.59, with a midpoint forecast of $17.89. The stock might deliver a +462.58% gain.
June 2027
Forecasting for June 2027, models estimate that Esperion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $14.13 and $16.78, averaging $15.23. This signals a positive trajectory with potential returns around +378.93%.
July 2027
According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in July 2027. The price is predicted to move between $13.97 and $15.48, settling at an average of $14.48. This could translate to a +355.35% gain.
ESPR's history of dividends and stock splits also plays a role in long-term investor confidence.